Subvisible particulate matter is under increasing amounts of scrutiny in the field of parenteral and ophthalmic drug products. USP <1788> and <1788.3> explicitly recommend the use of flow imaging and ...
Drugmakers and pharmaceutical industry groups urged the US Food and Drug Administration (FDA) to align its classification categories for visible particles with the US Pharmacopoeia’s (USP) Chapter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results